Additionally, individuals with stable depression (defined as full or partial remission) showed a greater improvement in alanine aminotransferase and gamma-glutamyltransferase levels after a year of standard care than patients with unstable depression (not in full or partial remission) [25]. The gene discussed is GPT; the disease is depressive symptom measurement.